Dtsch Med Wochenschr 2011; 136(21): 1123-1127
DOI: 10.1055/s-0031-1280522
Prinzip & Perspektive | Review article
Diabetologie
© Georg Thieme Verlag KG Stuttgart · New York

Die Rolle der Betazelle im Diabetes mellitus

The beta cell in diabetesS. Lenzen1
  • 1Institut für Klinische Biochemie, Medizinische Hochschule Hannover
Further Information

Publication History

eingereicht: 11.1.2011

akzeptiert: 17.3.2011

Publication Date:
17 May 2011 (online)

Literatur

  • 1 Bluestone J A, Auchincloss H, Nepom G T. et al . The Immune Tolerance Network at 10 years: tolerance research at the bedside.  Nat Rev Immunol. 2010;  10 797-803
  • 2 Cnop M, Welsh N, Jonas J C. et al . Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.  Diabetes. 2005;  54 (Suppl 2) S97-107
  • 3 Eisenbarth G S. Type 1 diabetes. Molecular, cellular and clinical immunology. Book. Online Edition version 3.0 ed;. http://www.barbaradaviscenter.org/ 2010
  • 4 Eizirik D L, Colli M L, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes.  Nature reviews. 2009;  5 219-226
  • 5 Elsner M, Gehrmann W, Lenzen S. Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells.  Diabetes. 2011;  60 200-218
  • 6 Gehrmann W, Elsner M, Lenzen S. Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic beta-cells.  Diabetes, obesity & metabolism. 2010;  12 (Suppl 2) 149-158
  • 7 Gurgul E, Lortz S, Tiedge M, Jörns A, Lenzen S. Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines.  Diabetes. 2004;  53 2271-2280
  • 8 Jörns A, Günther A, Hedrich H J. et al . Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat.  Diabetes. 2005;  54 2041-2052
  • 9 Leahy J L, Hirsch I B, Peterson K A, Schneider D. Targeting beta-cell function early in the course of therapy for type 2 diabetes mellitus.  The Journal of clinical endocrinology and metabolism. 2010;  95 4206-4216
  • 10 Lenzen S. Oxidative stress: the vulnerable beta-cell.  Biochemical Society transactions. 2008;  36 343-347
  • 11 Rahier J, Guiot Y, Goebbels R M, Sempoux C, Henquin J C. Pancreatic beta-cell mass in European subjects with type 2 diabetes.  Diabetes, obesity & metabolism. 2008;  10 (Suppl 4) 32-42
  • 12 Schloot N C. Immunintervention zum Betazellerhalt bei Typ-1-Diabetes.  Dtsch Med Wochenschr. 2010;  135 915-921
  • 13 Tiedge M, Lortz S, Drinkgern J, Lenzen S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells.  Diabetes. 1997;  46 1733-1742
  • 14 Waldhäusl W, Lenzen S S. Kapitel 14. Kohlenhydratstoffwechsel. In: Schwarz S, Förster O, Peterlik M, Schauenstein K, Wick G, ed. Pathophysiologie – Molekulare, zelluläre, systemische Grundlagen von Erkrankungen.. Wien: Wilhelm Maudrich Verlag; 2007

Prof. Dr. med. Sigurd Lenzen

Institut für Klinische Biochemie
Medizinische Hochschule Hannover

Carl-Neuberg-Str. 1

30625 Hannover

Phone: 0511/532-6525

Fax: 0511/532-3584

Email: lenzen.sigurd@mh-hannover.de